

Author: Rudyk H. Knaggs M.H. Vasiljevic S. Hope J. Birkett C. Gilbert I.H.
Publisher: Elsevier
ISSN: 0223-5234
Source: European Journal of Medicinal Chemistry, Vol.38, Iss.6, 2003-06, pp. : 567-579
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Congo red analogues as potential anti-prion agents
By Villa S. Cignarella G. Barlocco D. Gervasoni M. Carcassola G. Giannino L. Mantegazza P.
Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. :


By Mabbott Neil A Head Mark W Farquhar Christine F Fraser Janet R
Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. :




Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 1, 2009-02 ,pp. :